Quantcast

Latest Hodgkin's lymphoma Stories

2014-09-03 12:26:23

Leukemia Cup Regatta to Take Place September 20-21 at The San Francisco Yacht Club SAN FRANCISCO, Sept. 3, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will be hosting its ninth annual Leukemia Cup Regatta on September 20-21, 2014 at The San Francisco Yacht Club (SFYC) in Belvedere, Calif. The event will begin with the VIP Dinner on September 20 with special guest speaker Wendy Schmidt, president of the Schmidt Family Foundation...

2014-09-02 12:28:40

Home Decor Retailer Launches National In-Store Fundraiser and Sponsors Light The Night Walks to Support Cancer Cures PLANO, Texas, Sept. 2, 2014 /PRNewswire/ -- At Home, the home decor superstore, announced today a national partnership with The Leukemia & Lymphoma Society (LLS), the world's largest voluntary health agency dedicated to finding cures for blood cancers. Throughout the month of September, Blood Cancer Awareness Month, At Home team members will be collecting $1, $5...

2014-09-01 23:01:09

MarketOptimizer.org adds “OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018” to its store. Overview of B-cell NHL, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines for DLBCL, FL, MZL and MCL. Dallas, Texas (PRWEB) September 01, 2014 The B-cell non-Hodgkin’s Lymphoma (NHL) treatment market value will experience moderate growth across six major markets (the US, France, Italy, Germany, Spain and the...

2014-08-28 08:27:53

WHITE PLAINS, N.Y., Aug. 28, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) and OncoPep have entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma (SMM), an asymptomatic stage of myeloma. The partnership is through LLS's Therapy Acceleration Program® (TAP), through which LLS forges collaborations with biotechnology companies to help bring therapies to patients faster. OncoPep is developing a...

2014-08-27 08:27:52

The Leukemia & Lymphoma Society to Raise $300,000 during September, Blood Cancer Awareness Month WHITE PLAINS, N.Y., Aug. 27, 2014 /PRNewswire/ -- Every three minutes, someone in the U.S. is diagnosed. More than 1.1 million Americans are living with, or in remission from, these diseases. Certain forms of these diseases are the most common types of cancer in children and adolescents younger than 20 years. Almost 150,000 Americans will be diagnosed with these cancers this year. There are few,...

2014-08-19 23:02:37

Lack of Access and Financial Burden May Contribute to Increased Mortality, CPIC Researchers Find Fremont, CA (PRWEB) August 19, 2014 Despite advances in treatment, lymphoma patients residing in low socioeconomic status (SES) neighborhoods experienced significantly worse survival than patients living in high SES neighborhoods, researchers at the Cancer Prevention Institute of California (CPIC) have reported. Those who live in the poorest communities have a 34 percent greater risk of dying...

2014-08-06 16:28:52

Participants to Produce Strategic Roadmap for Accelerating Lymphoma Treatment Advances WASHINGTON, Aug. 6, 2014 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, will hold its first ASH Meeting on Lymphoma Biology, a meeting focused on furthering the treatment of lymphoma, August 10-13 in Colorado Springs, Colorado. More than 350 lymphoma experts from around the...

2014-07-28 16:27:12

FLINT, Mich., July 28, 2014 /PRNewswire/ -- Diplomat, the nation's largest independent specialty pharmacy, announced today that it has been selected as a provider of Zydelig(®) tablets. Zydelig was approved by the U.S. Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers. "We are pleased to partner with Gilead and be included in the limited panel of distribution for Zydelig," said Gary Kadlec, R.Ph, President of Diplomat. "Our expertise in...

2014-07-28 16:26:36

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018https://www.reportbuyer.com/product/2225690/Global-Non-Hodgkin-Lymphoma-Therapeutics-Market-2014-2018.htmlAbout Non-Hodgkin Lymphoma (NHL) and its Diagnostic ProceduresNon-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the lymphocytes grow and die....

2014-07-23 16:28:25

WHITE PLAINS, N.Y., July 23, 2014 /PRNewswire-USNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of idelalisib to treat patients with relapsed chronic lymphocytic leukemia (CLL), follicular lymphoma (FL) and small lymphocytic lymphoma (SLL) is a significant advance for patients with these blood cancers. Idelalisib, which goes by the trade name Zydelig®, is a first-in-class inhibitor of PI3K delta, a protein that is highly expressed in many B-cell malignancies...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.